Search

All 1
Drugs 1
Targets 0
Indications 0
Pathways 0

Displaying 1 result

DrugBest match

Treosulfan

go.drugbank.com/drugs/DB11678

ApprovedInvestigational

Treosulfan is a prodrug alternative to busulfan for myeloablative conditioning prior to hematopoietic stem cell transplantation. It was approved by the EMA in June 2019 and by the FDA in January 2025 for use in combination with fludarabine.